Keizai Report

Dienstag, 14. März 2006
(English Translation)

HUMANIX, a spin-off company of Hiroshima University, concluded a contract with CovalX

A spin-off company of Hiroshima University, HUMANIX (1-2-3 Kasumi, Minami-ku, President: Professor Tsutomu Masujima), participated in the medical mission to Europe last November and has established a tie with CovalX in Switzerland, with which HUMANIX has concluded a sales contract.

HUMANIX will distribute the products of CovalX in Japan including protein mass analyzers. CovalX was established in 2005 as a spin-off company of the Swiss Federal Institute of Technology in Zurich. HUMANIX, a venture company to make use of the findings of research works at Hiroshima University, develops and markets biological analyzers and promotes international collaboration with similar companies and research institutions in Switzerland for developing new analytical equipment through the Swiss-Hiroshima international collaboration of industry and academia promoted by Hiroshima University.